| Trial Identifier: | D133FR00176 |
| Sponsor: | AstraZeneca |
| Collaborator: |
INCUNA (Scientific and Technical partner)
|
| NCTID:: | NCT05091437 |
| Start Date: | December 2021 |
| Primary Completion Date: | June 2025 |
| Study Completion Date: | June 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Argentina | CABA, Argentina |
| Argentina, Neuquen | Neuquen, Argentina, 8300 |
| Brazil | Porto Alegre, Brazil |
| Brazil | Rio de Janeiro, Brazil |
| Brazil | Sao Paulo, Brazil |
| Chile | Antofagasta, Chile |
| Chile | Concepción, Chile |
| Chile | Providencia, Chile |
| Colombia | Bogota, Colombia |
| Colombia, Cundinamarca | Cundinamarca, Colombia |
| Costa Rica | San Jose, Costa Rica |
| Dominican Republic | Santo Domingo, Dominican Republic |
| Mexico | CDMX, Mexico |
| Mexico | Estado de Mexico, Mexico |
| Mexico, Nuevo Leon | Monterrey, Nuevo Leon, Mexico |
| Panama | Panama, Panama |
| Peru | Lima, Peru |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company